Description

Semaglutide

GLP-1 Receptor Agonist Peptide | Laboratory & Analytical Research

Semaglutide is a synthetic peptide and GLP-1 receptor agonist studied extensively in metabolic and endocrine research. PubChem identifies semaglutide as a lipopeptide with molecular formula C₁₈₇H₂₉₁N₄₅O₅₉ and molecular weight of approximately 4114 g/mol.

Semaglutide is relevant to laboratory research involving GLP-1 receptor biology, peptide chemistry, receptor signaling, glucose metabolism, metabolic pathways, analytical characterization, formulation science, and peptide stability.

Semaglutide Research Profile

Semaglutide is a modified GLP-1 analogue designed to interact with the GLP-1 receptor. Its molecular structure includes a long peptide chain together with a lipid-containing modification, making it suitable for research involving peptide structure, receptor interactions, and analytical characterization.

Laboratory research may examine semaglutide for its molecular identity, purity, assay, stability, degradation characteristics, and receptor-related properties.

Semaglutide Chemical Information

Specification Details
Product Name Semaglutide
Compound Type Synthetic peptide / lipopeptide
Pharmacological Class GLP-1 receptor agonist
Molecular Formula C₁₈₇H₂₉₁N₄₅O₅₉
Molecular Weight Approximately 4114 g/mol
Research Areas Peptide chemistry, receptor biology, metabolic research
PubChem CID 56843331

The formula and molecular weight above are from PubChem’s current semaglutide record.

Semaglutide Research Applications

Semaglutide may be investigated in controlled laboratory research involving:

  • GLP-1 receptor biology
  • Peptide chemistry
  • Receptor-signaling research
  • Glucose metabolism
  • Endocrine research
  • Metabolic biology
  • Molecular characterization
  • Analytical chemistry
  • Purity and assay testing
  • Peptide stability studies
  • Formulation research
  • Comparative peptide research

Key Characteristics

Defined Peptide Compound

Semaglutide is a chemically characterized peptide compound with a defined molecular structure that can be evaluated using suitable analytical methods.

GLP-1 Receptor Research

Semaglutide is a GLP-1 receptor agonist, making it relevant to research into receptor-mediated signaling and related metabolic pathways.

Analytical Characterization

Research laboratories may assess identity, purity, molecular mass, concentration, stability, and degradation products using validated analytical methods.

Formulation Research

Semaglutide may also be evaluated in research involving formulation characteristics, peptide integrity, and stability under controlled conditions.

Semaglutide Product Specifications

Product Name: Semaglutide
Product Type: Synthetic peptide / lipopeptide
Pharmacological Class: GLP-1 receptor agonist
Molecular Formula: C₁₈₇H₂₉₁N₄₅O₅₉
Molecular Weight: Approximately 4114 g/mol
Intended Application: Laboratory and analytical research

Available Research Quantities

Your current page lists:

  • 2 mg × 10 vials
  • 5 mg × 10 vials
  • 10 mg × 10 vials
  • 15 mg × 10 vials
  • 20 mg × 10 vials
  • 30 mg × 10 vials

Quality & Documentation

Depending on the supplied material, product documentation may include:

  • Peptide identity
  • Purity or assay
  • Molecular-weight information
  • Batch or lot number
  • Certificate of Analysis (COA)
  • Analytical testing
  • Stability information
  • Product specifications

The actual label and batch-specific COA should be treated as the definitive source for the exact material supplied.

Semaglutide Regulatory Background

Semaglutide is an established active pharmaceutical ingredient in FDA-approved products, including Ozempic, Rybelsus, and Wegovy. FDA records identify these products as semaglutide products and describe GLP-1 receptor agonist indications for the respective approved formulations.

That approval applies to the specific pharmaceutical products and their approved formulations and labeling. It should not be used to represent a separately supplied research material as an FDA-approved medicine.

Important Research Information

Semaglutide is a biologically active pharmaceutical compound. Product identity, purity, concentration, formulation, and batch characteristics should be verified using the applicable manufacturer documentation.

This page is provided for scientific, analytical, compound-identification, and legitimate laboratory research information. It does not provide dosing, administration, treatment, or therapeutic-use instructions.